Access to European Union law
<a href="https://eur-lex.europa.eu/content/help/eurlex-content/experimental-features.html" target="_blank">More about the experimental features corner</a>
Choose the experimental features you want to try
EUR-Lex
Access to European Union law

This document is an excerpt from the EUR-Lex website

You are here
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search

Document 52003XC1128(01)

    Summary of Community decisions on marketing authorisations in respect of medicinal products from 15 October 2003 to 15 November 2003 (Published pursuant to Article 12 or Article 34 of Council Regulation (EEC) No 2309/93)

    OB C 285, 28.11.2003, p. 2–6 (ES, DA, DE, EL, EN, FR, IT, NL, PT, FI, SV)

    52003XC1128(01)

    Summary of Community decisions on marketing authorisations in respect of medicinal products from 15 October 2003 to 15 November 2003 (Published pursuant to Article 12 or Article 34 of Council Regulation (EEC) No 2309/93)

    Official Journal C 285 , 28/11/2003 P. 0002 - 0006


    Summary of Community decisions on marketing authorisations in respect of medicinal products from 15 October 2003 to 15 November 2003

    (Published pursuant to Article 12 or Article 34 of Council Regulation (EEC) No 2309/93(1))

    (2003/C 285/02)

    - Issuing of a marketing authorisation (Article 12 of Regulation (EEC) No 2309/93): Accepted

    >TABLE>

    - Modification of a marketing authorisation (Article 12 of Regulation (EEC) No 2309/93): Accepted

    >TABLE>

    - Modification of a marketing authorisation (Article 12 of Regulation (EEC) No 2309/93): Rejected

    >TABLE>

    - Issuing of a marketing authorisation (Article 34 of Regulation (EEC) No 2309/93): Accepted

    >TABLE>

    - Modification of a marketing authorisation (Article 34 of Regulation (EEC) No 2309/93): Accepted

    >TABLE>

    Anyone wishing to consult the public assessment report on the medicinal products in question and the decisions relating thereto is invited to contact: The European Agency for the Evaluation of Medicinal products 7 Westferry Circus

    Canary Wharf

    London E14 4HB United Kingdom.

    (1) OJ L 214, 24.8.1993, p. 1.

    Top